Industry Insights - The low-altitude economy market in China is expected to reach 1.5 trillion yuan by 2025, with potential to exceed 2 trillion yuan by 2030, indicating strong growth in the industry [1] - As of now, the annual box office for Chinese films in 2025 has surpassed 46 billion yuan, with over 50 new films expected to be released in November [1] Company News - Zhongshui Fishery has experienced a stock price increase with a cumulative deviation of over 20% in closing prices over two trading days, indicating potential irrational trading behavior and risks of price correction [3] - Jiahua Technology is planning to acquire a controlling stake in Shudun Technology, which may constitute a major asset restructuring, leading to a suspension of trading for up to five days [3] - CITIC Bank has received approval for its subsidiary to commence operations, focusing on market-oriented debt-to-equity swaps and equity investments in strategic emerging industries [3] - Jinfu Technology is planning to acquire at least 51% of Guangdong Lanyuan Technology, which is expected to enhance the company's profitability and risk resistance [4] - Zhongding Co. is entering a strategic cooperation with Shanghai Fourier Intelligent Technology to develop humanoid robot components [4] - JinkoSolar has announced the mass production of its Tiger Neo 3.0 solar module, achieving a production efficiency of over 24.8% and a power output of up to 670W [4] - Zhongjin Lingnan plans to acquire stakes in Zhongjin Copper and Zhongjin Rongsheng for a total consideration of 742 million yuan [5] - Qingmu Technology's subsidiary is set to acquire a 65.83% stake in Vitalis, becoming its controlling shareholder [5]

Industry Overview - The cosmetics and medical beauty sector has shown stronger performance than the market, with the Shenwan Beauty Care Index declining by 4.5% from November 14 to November 21, 2025, outperforming the Shenwan A Index by 1.9 percentage points [3][4] - The cosmetics sales are expected to gradually decline as the peak shopping season ends, with domestic brands actively preparing new products for the off-season [9][10] Key Insights - The 2026 cosmetics and medical beauty strategy report indicates that brand growth is crucial, with upstream and downstream margins improving. Domestic brands are expected to grow against the trend during the industry consolidation phase [10][11] - The National Medical Products Administration has introduced 24 reform measures aimed at enhancing the regulatory framework for cosmetics, promoting high-quality industry development [26] Company Focus - Qingmu Technology (301110) is highlighted as a full-domain operation service expert, leveraging data and technology to drive growth. The company has established a strong brand matrix across various sectors, including fashion and beauty [15][16] - Investment recommendations include brands with strong channel and brand matrices such as Maogeping, Shangmei Co., and Proya, as well as companies in the medical beauty sector like Aimeike [12][14] Market Trends - The retail sales of cosmetics in October 2025 grew by 9.6%, driven by the Double 11 shopping festival, with a total retail sales of 381.3 billion yuan for cosmetics in the first ten months of 2025, reflecting a 4.6% year-on-year increase [21][23] - The domestic market for skincare products is expected to see further growth, with domestic brands gaining market share due to their competitive pricing and localized strategies [31][34]

Investment Rating - The investment rating for the social services industry is "Positive" (maintained) [1] Core Insights - The report highlights a strong performance in the tourism sector, with Ctrip achieving a revenue of 18.37 billion yuan, a year-on-year increase of 15.5% [17] - The report indicates a structural shift in the toy industry, with a net closure of 9 stores in October 2025, leading to a total of 3,967 stores [29] - The restaurant industry is experiencing a contraction in tea supply while coffee continues to grow, with Haidilao focusing on increasing its takeout sales [36] Summary by Sections Ctrip Performance - Ctrip's Q3 2025 revenue reached 18.37 billion yuan, reflecting a year-on-year growth of 15.5% [17] - The adjusted EBITDA for Ctrip was 6.35 billion yuan, up 11.7% year-on-year [22] - The revenue breakdown shows ticketing, accommodation, vacation, and business travel management growing by 11.6%, 18.3%, 3.1%, and 15.2% respectively [21] Toy Industry - As of October 2025, the number of offline toy stores in China was 3,967, with a net decrease of 9 stores [29] - The average store efficiency for toy brands increased by 10% year-on-year, with top brands like Pop Mart showing significant growth [31] Restaurant Industry - The tea beverage sector is entering a contraction phase, while the coffee sector is accelerating [36] - As of October 2025, the average monthly store efficiency for the tea industry was 212,400 yuan, a 5.8% increase year-on-year [39] - The coffee industry saw a net increase of 5,600 stores, with an average monthly store efficiency of 289,000 yuan, up 1.2% year-on-year [39]

Group 1: Mergers and Acquisitions - JiaHua Technology plans to acquire controlling stake in Shudun Technology through a combination of share issuance and cash payment, with the transaction potentially constituting a major asset restructuring [1] - JinFu Technology is planning to acquire at least 51% stake in Guangdong Lanyuan Technology to expand its second main business growth curve, enhancing profitability and risk resistance [2] - QingMu Technology's wholly-owned subsidiary intends to purchase 49.0662% of Vitalis Pharma AS for 150 million Norwegian Krone (approximately 106 million RMB) in cash, along with subscribing for an additional 32.9157% stake, resulting in a total holding of 65.8314% [3] - ZhongJin LingNan is acquiring minority stakes from shareholders in Shandong ZhongJin LingNan Copper Industry and ZhongJin LingNan Rongsheng (Dongying) Investment, aiming for 100% ownership of the former [4] Group 2: Shareholding Changes - ShenShui HaiNa's major shareholder, AnYi ShenShui, plans to reduce its stake by up to 1%, amounting to a maximum of 1.7728 million shares [5] - AnDa Intelligent's shareholder, Dongguan YiZhiTong, intends to reduce its stake by up to 2.74%, equating to a maximum of 2.2503 million shares [6] - GuangLi Micro's shareholders, WuYueFeng and associated parties, plan to collectively reduce their stake by up to 2.24%, totaling a maximum of 4.4062 million shares [7]

Core Viewpoint - Qingmu Technology (301110) is expanding its business through a significant acquisition, aiming to enhance its brand incubation and management strategy in the health and wellness sector [1][4]. Group 1: Acquisition Details - Qingmu Technology's subsidiary, Qingmu Singapore, signed a share purchase and subscription agreement to acquire 49.07% of the target company's shares from Norsund for 150 million Norwegian Krone (approximately 106 million RMB) and to subscribe for an additional 32.92% of new shares for the same amount [1]. - After the completion of this transaction, Qingmu Singapore will hold a total of 65.83% of the target company, becoming its controlling shareholder, and the target company will be included in Qingmu's consolidated financial statements [1]. Group 2: Business Model and Services - Qingmu Technology provides comprehensive e-commerce services, including e-commerce operation, channel distribution, and retail services, catering to well-known domestic and international brands [1][2]. - The company has established a complete e-commerce ecosystem, collaborating with major platforms such as Tmall, JD.com, Douyin, Xiaohongshu, and Vipshop, and offers a full range of services from traditional e-commerce operations to digital marketing and consumer engagement [2]. Group 3: Growth Strategy - The brand incubation and management business is identified as the company's second growth curve, with a focus on health consumer products. The company plans to invest more in this area and introduce overseas quality brands through various methods, including joint ventures and acquisitions [3]. - The company reported significant revenue growth for its incubated brands, with Cumlaude Lab and ZUCCARI achieving over 70% and 95% year-on-year growth, respectively, in the first half of 2025 [3]. Group 4: Future Outlook - The acquisition aims to strengthen the company's capabilities in brand management, research and development, production, and supply chain management in the health supplement sector, enhancing its competitive edge [4]. - Qingmu Technology aspires to become a "data and technology-driven retail service expert," focusing on the application of new technologies like AI to improve operational efficiency [3].

Group 1: Major Announcements - Jiahua Technology plans to acquire controlling stake in Shudun Technology through a combination of share issuance and cash payment, leading to a potential major asset restructuring, with stock suspension starting from November 24, 2025, for up to 5 trading days [2] - China Merchants Bank's wholly-owned subsidiary, China Merchants Financial Asset Investment Co., has received approval to commence operations with a registered capital of 15 billion yuan, focusing on market-oriented debt-to-equity swaps and equity investment pilot projects [3] - CITIC Bank's wholly-owned subsidiary, Xinyin Financial Investment Co., has also been approved to start operations with a registered capital of 10 billion yuan, targeting strategic emerging industries and specialized sectors for market-oriented debt-to-equity swaps and equity investments [4] Group 2: Stock Performance and Risks - Zhongshui Fishery's stock has seen a significant price increase followed by a potential decline, with a rolling P/E ratio of 77.53 and a P/B ratio of 13.48, indicating substantial deviation from industry averages and raising concerns over irrational trading behavior [5] - Caixin Development's stock has also experienced a price deviation exceeding 20%, with uncertainty surrounding the bankruptcy restructuring of its controlling and indirect controlling shareholders, which may affect the company's control dynamics [6] Group 3: Acquisitions and Strategic Moves - Zhongjin Lingnan has acquired minority stakes in its subsidiaries, purchasing 4.2095% of Zhongjin Copper for 242 million yuan and 10.3333% of Zhongjin Rongsheng for 365 million yuan, among other transactions, resulting in full ownership of Zhongjin Copper [7] - Baili Tianheng's drug application for Iza-bren, a first-in-class treatment for advanced or metastatic nasopharyngeal carcinoma, has been accepted by the National Medical Products Administration [8] - Jinfut Technology is planning to acquire at least 51% of Guangdong Lanyuan Technology through cash payment, which is expected to enhance the company's profitability and risk resistance [9] - Qingmu Technology's subsidiary plans to acquire control of Vitalis for 150 million Norwegian kroner (approximately 106 million yuan), aiming to strengthen its position in the health and nutrition supplement market [12] - Zhongding Co. is entering a strategic partnership with Fourier for humanoid robot components, enhancing its product development capabilities [11] Group 4: Leadership Changes - Guiguan Network's chairman Chen Yu has resigned due to work changes, with a new candidate recommended to take over the chairman role [13] Group 5: Shareholding Changes - Shen Shui Haina's shareholder plans to reduce holdings by up to 1% within three months, while other shareholders of Guangli Micro plan to reduce holdings by up to 2.2359% [14][15] - Andar Intelligent's shareholder intends to reduce holdings by up to 2.7401% within three months [16] Group 6: Contracts and Orders - Nenghui Technology has signed a contract for a new energy power battery assembly with an estimated total price of 100 million yuan [17] - Jinko Solar has achieved cumulative orders of 15GW for its Tiger Neo3.0 module, which has a production efficiency exceeding 24.8% and a maximum power output of 670W [18]

标的公司主要从事高端健康营养补充剂的研发、生产及销售，旗下拥有Noromega等品牌，主要产品包 括海豹油、鱼油、虾青素、辅酶Q10等系列产品。本次并购目的是落实公司品牌孵化及管理业务发展战 略，加强公司在大健康赛道的布局和竞争力。本次交易完成后，将增强公司在品牌管理、健康营养补充 剂产品的研发、生产及供应链管理等方面的综合能力，并补充公司旗下自有品牌，以及公司的全资子公 司将成为Noromega品牌的中国区总经销商，将有利于提升公司的持续盈利能力。 智通财经APP讯，青木科技(301110.SZ)发布公告，公司的全资子公司QINGMU PTE.LTD.(简称"青木新 加坡")与Norsund Gruppen AS(简称"Norsund")、YunlinZHAN签署《股份购买及认购协议》，与 Norsund、Yunlin ZHAN及Vitalis Pharma AS(简称"Vitalis"或"标的公司")签署《新股认购协议》，以及相 关附属协议(《股份购买及认购协议》、《新股认购协议》及相关附属协议合称"收购协议")。根据收购 协议，青木新加坡将以1.5亿挪威克朗(约合人民币1.06亿元)现金购买Norsun ...

Group 1 - The core point of the news is that Qingmu Technology's subsidiary, Qingmu PTE. LTD., has signed a share purchase and subscription agreement to acquire a 49.0662% stake in Vitalis Pharma AS for 150 million Norwegian Krone (approximately 106 million RMB) and to subscribe for an additional 32.9157% stake for the same amount, resulting in a total ownership of 65.8314% and making it the controlling shareholder of the target company [1][2] Group 2 - The target company specializes in the research, production, and sales of high-end health nutritional supplements, with brands such as Noromega, and its main products include seal oil, fish oil, astaxanthin, and coenzyme Q10 [2] - The purpose of the acquisition is to implement the company's brand incubation and management strategy, enhancing its competitiveness in the health sector [2] - Post-transaction, the company will strengthen its capabilities in brand management, product research and development, production, and supply chain management, and will become the general distributor for the Noromega brand in China, which is expected to improve its sustainable profitability [2]

证券代码：301110 证券简称：青木科技 公告编号：2025-062 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、青木科技股份有限公司（以下简称"公司"）本次交易事项需履行境外 投资备案手续。目前公司尚未取得标的公司的股权，若无法顺利完成交割，本次 交易存在终止的风险。 2、标的股权的收购价格为3.00亿挪威克朗（约合人民币2.12亿元），预 计将形成较大金额商誉，存在商誉减值风险。 3、由于在地域文化、管理方式上存在一定程度的差异，本次股权购买完成 后，若不能有效进行企业文化理解和资源优势互补整合，可能会给公司经营管理 和业务整合协同带来一定的风险。 本次交易的交割尚需取得必要的备案或批准，并满足协议约定的与标的公 司运营相关的其他交割先决条件，因此本次交易具体实施尚存在不确定性，敬请 广大投资者注意投资风险。 二、交易对方的基本情况 4、交易完成后，买方的关联方将获得标的公司品牌Noromega在中国区域的总 经销代理权，该代理权的取得预计将会对公司未来净利润产生积极影响。 敬请广大投资者注意投资风险。 一、交易概述 公司于2025年 ...

证券代码：301110 证券简称：青木科技 公告编号：2025-061 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 青木科技股份有限公司（以下简称"公司"）第三届董事会第十三次会议 于 2025 年 11 月 17 日以书面方式发出会议通知，会议于 2025 年 11 月 20 日 13:30 在公司会议室以现场结合通讯方式召开。本次会议由公司董事长吕斌先 生召集并主持。会议应出席董事 7 人，实际出席董事 7 人，其中非独立董事卢 彬先生、非独立董事吴志伟先生、非独立董事刘旭晖先生、独立董事韩慧博先 生、独立董事廖俊峰先生、独立董事王浩先生均以通讯方式出席。本次会议的 召集、召开程序符合《中华人民共和国公司法》及《青木科技股份有限公司章 程》《青木科技股份有限公司董事会议事规则》等有关法律、法规、规范性文 件的规定，程序合法。 二、董事会会议审议情况 为落实公司品牌孵化及管理业务发展战略，提升公司在健康食品领域的竞 争力，公司拟以自有资金通过全资子公司 QINGMU PTE. LTD.收购 Vitalis Pharma AS 的部 ...